BIOGNOSYS
21.10.2021 16:02:05 CEST | Business Wire | Press release
Biognosys, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced they will be presenting major scientific and technological advances on their proprietary proteomics research services, software, and kits at the American Society for Mass Spectrometry (ASMS) Annual Conference from October 31st to November 4th in Philadelphia (USA).
Biognosys will present a record number of 3 oral presentations, 10 scientific posters, 2 poster collaborations, 1 workshop panel, and 2 Spectronaut™ breakfast seminars . In addition, their team of scientific experts will be present at booth #224 to answer questions and demo software. Further demo sessions will be offered at the Bruker Daltonics booth #719.
Collectively, this presence demonstrates Biognosys’ significant contributions to transforming life science and clinical research with next-generation proteomics, particularly in the areas of plasma proteomics, immunopeptidomics, and proteomics data analysis.
Lukas Reiter, PhD, Chief Technology Officer of Biognosys:
“Our major contribution to the ASMS scientific program is a testimony of Biognosys’ relentless commitment to innovation in mass spectrometry-based proteomics and progress in life science and clinical research.”
Discovering biomarkers in cancer with next-generation plasma proteomics
The plasma proteome is an underexplored source of insights on the health state of an individual. Biognosys will present results from a deep human plasma profiling study on a cohort of 180 lung, breast, colorectal, pancreatic, and prostate cancer patients, using an early version of their next-generation Plasma Biomarker Discovery workflow, launching in November. The workflow is optimized for use on Thermo Fisher Scientific Exploris 480 and FAIMS Pro instruments. Out of the entire plasma proteome, they quantified over 2,700 proteins and identified a protein panel with a significant positive predictive value for individual cancer stages.
Andreas Huhmer, Senior Director Life Sciences Research OMICS Marketing
at Thermo Fisher Scientific:
“Biognosys has a proven track record for maximizing all innovative features of the Thermo Scientific™ Orbitrap™ mass spectrometers in state-of-the-art proteome analysis. Their new Plasma Biomarker Discovery workflow is a good example of this. The unprecedented depth and quantitative precision they can achieve, coupled with the inherently unbiased nature of mass spectrometry-based analysis, has the potential to take plasma biomarker discovery to the next level.”
Gaining insights on the immune system to support personalized drug development
Immunopeptides play an essential role in the immune system and can be analyzed to support the development of personalized treatments. Mass spectrometry is currently the only technology that can reliably measure and identify immunopeptide profiles of biological samples on a large scale. Biognosys will present their immunopeptidomics workflow, optimized to provide deep and comprehensive biological insights on the immune system in large-scale clinical studies.
Turning data to insights with Spectronaut™, SpectroMine™, and SpectroDive™
Biognosys provides leading software products for proteomics data analysis. In a series of talks, their team will detail how they leverage the latest developments in Machine Learning and Deep Learning to allow deeper insights into the proteome. Biognosys is also excited to host two breakfast seminars with three guest speakers sharing their latest results from using Spectronaut in their research projects. In addition, a sneak-peak into the next planned release will be disclosed.
Gary Kruppa, Vice President, Proteomics at Bruker Daltonics:
“Biognosys’ software tools are among the top solutions for the analysis of proteomics data generated with Bruker instruments. Particularly the latest Spectronaut version yields spectacular performance improvements for dia-PASEF data. We invite all Bruker users to experience Spectronaut’s capabilities and enjoy the exceptional support Biognosys provides.”
Visit biognosys.com/asms2021 for a complete overview of Biognosys’ presence at ASMS.
About Biognosys
Biognosys is a leader in next-generation proteomics, dedicated to transforming life science by inventing and developing cutting-edge proteomics technology and solutions and making them widely available for pharmaceutical and biotechnology researchers and proteomics experts. The Company offers a versatile portfolio of proprietary proteomics services, software, and kits that provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Biognosys’ unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins across thousands of samples with industry-leading precision, depth, and throughput. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research. More information at biognosys.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211021005530/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Textron Aviation Opens New Melbourne Service Facility at Essendon Fields Airport, Expanding Support for Cessna, Beechcraft and Hawker Customers in APAC5.5.2026 17:00:00 CEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced its new service facility at Essendon Fields Airport in Melbourne is now open for customers, expanding factory-direct support for Cessna, Beechcraft and Hawker customers across Australia and the Asia-Pacific region. The purpose-built facility strengthens Textron Aviation’s global service network and reflects the company’s long-term commitment to expanding capacity and enhancing customer support throughout aircraft ownership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505135152/en/ Textron Aviation opens new Melbourne service facility at Essendon Fields airport, expanding support for Cessna, Beechcraft and Hawker customers in APAC “We’ve supported customers in Australia for decades, and we continue to invest where our customers tell us they need more capacity and faster access to factory direct expertise,” said Brian Rohloff, senior vice presiden
Doha Debates Podcast Examines the Global Questions Shaping Society5.5.2026 16:37:00 CEST | Press release
Weekly Tuesday releases from January 6 through June 2 extend conversations from Doha Debates’ flagship debates and global town halls Qatar Foundation’s Doha Debates continues the rollout of its weekly Doha Debates Podcast episodes, airing every Tuesday through June 2. Since launching on January 6, the season has brought leading global thinkers into direct conversation on the defining questions of our time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505299576/en/ Doha Debates podcast examines the global questions shaping society. Weekly Tuesday releases from January 6 through June 2 extend conversations from Doha Debates’ flagship debates and global town halls. (Photo: AETOSWire) The Doha Debates Podcast extends themes first explored in Doha Debates’ flagship debates and town halls, offering deeper, sustained exchanges that connect disciplines, regions and worldviews through open, truth-seeking dialogue. The latest epi
INRIX Unveils Global Standard for Traffic Signal Intelligence5.5.2026 16:34:00 CEST | Press release
Latest updates to INRIX Signal Analytics deliver expanded scale, confidence, and performance insight for cities worldwide INRIX, a global leader in transportation analytics and mobility intelligence, today announced a series of major updates to its award-winning Signal AnalyticsTM platform. These updates deliver unprecedented scale, statistical confidence, and flexibility by combining INRIX’s proven signal performance methodology with newly integrated traffic data, creating the most comprehensive, data-richsignal analytics solution to date. “INRIX Signal Analytics saves hours of monitoring every week by identifying where problems exist and enabling data-driven decisions that improve efficiency and safety at our intersections. It has been a valuable tool for optimizing our signal operations,” said Aaron M Torres, Traffic Operations Manager, Osceola County, Florida. With these updates, transportation agencies can now monitor, diagnose, and improve signalized intersections without install
Convatec’s Advanced Wound Care Innovation Leads the Industry at European Wound Management Association (EWMA) 20265.5.2026 16:11:00 CEST | Press release
Convatec will showcase new clinical and real‑world evidence across next‑generation foam technology, nitric oxide‑generating dressings, and Wound HygieneConvatec-sponsored scientific symposia to spotlight patient-centred innovation supported by robust in-vitro and clinical data enabling HCPs to deliver better outcomesConvatec to unveil Aquacel™ ConvaFiber™ in its European debut ahead of scale-up later this year Convatec, a leading medical products and technology company focused on chronic condition management, takes to the stage to showcase the breadth, depth and momentum behind its Advanced Wound Care innovation pipeline at the European Wound Management Association (EWMA) 2026 conference in Bremen, Germany, from 6–8 May 2026. Convatec’s industry-leading Advanced Wound Care innovation is supported by compelling new data from randomised controlled trials (RCTs) and real-world studies, with 13 abstracts accepted for publication and presentation at EWMA evaluating outcomes in hard-to-heal
Laserfiche Recognized as a Leader in 2026 Gartner® Magic Quadrant™ for Document Management5.5.2026 16:00:00 CEST | Press release
Laserfiche named a Leader for the second consecutive time based on its Completeness of Vision and Ability to Execute Laserfiche — the leading SaaS provider of intelligent content management — has been positioned as a Leader in the 2026 Magic Quadrant for Document Management. Laserfiche believes this recognition underscores the company’s commitment to empowering organizations to transform complex, operational business processes through AI-powered content management. “It’s incredible to see Laserfiche recognized during the same week as our annual Empower conference, where we announced our latest agentic AI capabilities,” said Thomas Phelps, senior vice president of corporate strategy and chief information officer at Laserfiche. “We believe being positioned as a Leader — and receiving the highest overall rating among 16 vendors in Gartner Peer Insights, with a 4.7 out of 5.0 based on over 1,300 reviews as of April 30, 2026 — reflects our relentless focus on product innovation and deliveri
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom